rs28935203
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000132.4(F8):c.5096A>T(p.Tyr1699Phe) variant causes a missense change. The variant allele was found at a frequency of 0.000000912 in 1,096,156 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y1699C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000132.4 missense
Scores
Clinical Significance
Conservation
Publications
- hemophilia AInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- mild hemophilia AInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- moderately severe hemophilia AInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- severe hemophilia AInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- symptomatic form of hemophilia A in female carriersInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| F8 | NM_000132.4 | c.5096A>T | p.Tyr1699Phe | missense_variant | Exon 14 of 26 | ENST00000360256.9 | NP_000123.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| F8 | ENST00000360256.9 | c.5096A>T | p.Tyr1699Phe | missense_variant | Exon 14 of 26 | 1 | NM_000132.4 | ENSP00000353393.4 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD2 exomes AF: 0.00000554 AC: 1AN: 180470 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 9.12e-7 AC: 1AN: 1096156Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 361732 show subpopulations
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Hereditary factor VIII deficiency disease Pathogenic:3
- -
- -
Variant summary: F8 c.5096A>T (p.Tyr1699Phe) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.5e-06 in 180470 control chromosomes. c.5096A>T has been reported in the literature in multiple individuals affected with Factor VIII Deficiency (Hemophilia A). These data indicate that the variant is very likely to be associated with disease. The following publication have been ascertained in the context of this evaluation (PMID: 23926300). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Pathogenic:2
Published functional studies demonstrate a damaging effect (PMID: 30997536); In silico analysis indicates that this missense variant does not alter protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); Also known as (p.Y1680F); This variant is associated with the following publications: (PMID: 19473423, 24108539, 10368977, 1554716, 1898735, 21940821, 11857744, 8547094, 17958741, 27378673, 33552050, 32791533, 32232366, 24452774, 21909383, 2105906, 18691168, 19302446, 33314404, 27629384, 32299908, 1908096, 30997536) -
The F8 c.5096A>T; p.Tyr1699Phe variant (rs28935203), also known as Tyr1680Phe, is reported in the literature in multiple individuals affected with mild to moderate hemophilia A (see link to FVIII database and references therein). This variant is reported in ClinVar (Variation ID: 10115), and is only observed on one allele in the Genome Aggregation Database, indicating it is not a common polymorphism. tyrosine at codon 1699 is highly conserved, and computational analyses predict that this variant is deleterious (REVEL: 0.779). Based on available information, the p.Tyr1699Phe variant is considered to be pathogenic. References: Link to variant in FVIII variant database: http://www.factorviii-db.org/ -
Inborn genetic diseases Pathogenic:1
The c.5096A>T (p.Y1699F) alteration is located in exon 14 (coding exon 14) of the F8 gene. This alteration results from a A to T substitution at nucleotide position 5096, causing the tyrosine (Y) at amino acid position 1699 to be replaced by a phenylalanine (F). Based on data from gnomAD, the T allele has an overall frequency of 0.001% (1/180470) total alleles studied, with 0 hemizygotes. The highest observed frequency was 0.001% (1/80944) of European (non-Finnish) alleles. This variant has been reported in multiple individuals with hemophilia A (Higuchi, 1990; Nance, 2013; Eckhardt, 2013; Pavlova, 2014; Nance, 2016). This amino acid position is highly conserved in available vertebrate species. In multiple assays testing F8 function, this variant showed functionally abnormal results (van den Biggelaar, 2011; Pahl, 2014). This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at